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INTRODUCTION
Austria has 15.4 pharmacies per 100,000 
inhabitants, which is a low density of phar-
macies compared to the OECD average of 
25. As a result, at least part of the popu-
lation is dependent on dispensing doctors 
(DDs) to receive prescribed medication, 
especially in rural areas. Approximately 
840 DDs supplement the drug supply of 
1,357 public pharmacies throughout the 
country (Federal Competition Authority, 
2018). Although DDs have a long history 
in Austria, they are regarded with am-
bivalence; the Medical Association and 
the Chamber of Pharmacists have had 
opposing positions for many years (e.g. 
Bunda, 2019; Reisinger and Pint, 2008). 
Arguments in favour of DDs are that they 
are positively received by the general pub-
lic (two thirds of the Austrian population 
consider DDs helpful (Bunda, 2019) and 
that they help to solve supply gaps (clo-
sures of DDs were associated with a dete-
rioration of the supply situation for 87% 
of the respondents). Furthermore, the 
dispensing system offers monetary incen-
tives for young doctors to settle in rural ar-
eas (Riedler, 2014) – an argument which 
is gaining in importance, since warnings 
of an extinction of rural physicians are 
becoming more frequent (Kriegel et al., 
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abstract
Objectives: Dispensing doctors (DDs) are a central part of the medication 
supply in Austria. Nevertheless, they are controversial and research pays 
little attention to perspectives of user-groups, especially older people. 
Therefore, this article deals with determinants of older people’s approval 
of dispensing doctors.
Methods: For this purpose, data from a telephone survey with people over 
60 years in Lower Austria are used and evaluated by means of a logit model.
Results: The results show that accessibility of medicines is a major reason 
for the preference of DDs. Key factors are availability of a pharmacy in close 
proximity (OR: 0.44), independent use of a car (OR: 1.54) and individual 
mobility due to health reasons (OR: 1.14).
Discussion: DDs are important for older people in terms of a spatially 
close drug supply. A pharmacy at the place of residence only outweighs the 
preference for DDs if it is actually accessible for older people (taking low 
travel costs into account).
Conclusions: The aim must be to improve access to medicines in all 
communities where there is no pharmacy within a reasonable distance for 
people with health problems or those with restricted mobility.
Keywords: Dispensing doctors; Lower Austria; Medication supply; 












Journal of Nursing, Social Studies, Public Health and Rehabilitation 3–4, 2020, pp. 70–76
71
Determinants of older people’s preferences for dispensing doctors
2016). On the other hand, the advantages of 
public pharmacies over DDs are emphasised: 
Pharmacies have longer opening hours and a 
wider range of products – which may explain 
why 91% of the population considers a phar-
macy in place of residence to be important 
(Reisinger and Pint, 2008). Additionally, the 
separation of prescription and dispensation is 
seen as an important control function in me-
dicinal distribution (Chamber of Pharmacists, 
2019). These arguments contribute to a lively 
political and economic discussion about the 
advantages of the respective systems which 
does not only pertain to Austria (Eggleston, 
2012; Hassali, 2015; Shafie et al., 2012).
Against this background, science has 
turned to the topic of dispensing regimes. The 
interest ranges from historical, economic and 
theoretical considerations on the separation 
of prescription and dispensation (Eggleston, 
2012) to coverage and shifts in pharmacies’ 
portfolios (Bannert and Iselin, 2015), dispens-
ing and prescribing patterns of physicians 
(Goldacre et al., 2019; Iizuka, 2008; Lim et al., 
2011; Liu et al., 2009; Trottmann et al., 2016; 
Weiss et al., 2016; Wilcock, 2001) with special 
regard to the health care expenditures (Beck 
et al., 2004; Kaiser and Schmid, 2016; Reich 
et al., 2012; Trottmann et al., 2016; Wilcock, 
2001) and to the effectiveness of dispensing 
regimes (Lim et al., 2014) e.g. in the preven-
tion of adverse events (Blozik et al., 2015; 
Meyer, 2016; Munger et al., 2014) or adher-
ence (Huber and Reich, 2016). Although the 
majority of international scientific evidence 
is likely to emphasise that DDs have some 
disadvantages such as higher health expendi-
tures – discussed as provider-induced-de-
mand or agency problems (Lim et al., 2009) – 
the findings are still surprisingly mixed 
(Goldacre et al., 2019; Trottmann et al., 2016). 
This is possibly due to the different national 
legal frameworks, which influence dispensing 
behaviours, or to methodological differences 
between the studies. In summary, separation 
and integration of prescription and dispensa-
tion both seem to have advantages and disad-
vantages, with scientific literature frequently 
pointing to the importance of DDs for the cov-
erage of drug supply in rural areas (e.g. Lim et 
al., 2014). It is remarkable that patients’ ideas 
and wishes regarding drug dispensation only 
play a minor role in this discourse (exceptions 
are Faisst et al., 2000; Hassali, 2015; Mung-
er et al., 2014; Perri et al., 1987; Pink et al., 
1989; Sunderland et al., 2006). Looking at the 
majority of the literature mentioned above, 
the quality of the health care system seems 
to be independent of the patient perspective 
on this issue. However, a few, more recent 
international studies including measures of 
patient preference also provide conflicting re-
sults: for example, the population in Malaysia 
was shown to be in favour of a separation of 
prescription and dispensation (Hassali, 2015) 
and assumes quality improvements, while 
the respondents to a Swiss study reported to 
be very satisfied with both pharmacies and 
DDs (Faisst et al., 2000). A study from the 
USA (Munger et al., 2014) concludes that pa-
tients see benefits from DDs as well as pre-
scription-dispensation separation, indicating 
a supplementary character of both dispensing 
systems (also Sunderland et al., 2006). Apart 
from these results, the preferences and atti-
tudes of health care system users are rarely 
taken into account in the debate on separation 
or integration of medication supply. To our 
knowledge there is no study that asks about 
the circumstances why patients or users of the 
health care system prefer to receive medica-
tion from the physician. Therefore, the aim of 
this article is to investigate determinants of 
older people’s approval of dispensing doctors 
to understand under which conditions they 
become more important.
We base our assumptions on Eggleston’s 
economic theory, which postulates that with 
increasing the perceived travel costs (these 
include not only the monetary costs, but all 
personally perceived costs, such as time or 
even pain one has on the way to the phar-
macy) in relation to human resources, the 
preference for integration (= DDs) increases 
(Eggleston, 2012). The author himself gives 
an example: ‘When a patient has a chronic 
disease, the travel costs associated with fre-
quent adjustment of prescriptions may also 
weigh in favor of integrating some diagnosis 
and dispensing functions.’ Against this back-
ground, we assume that a poor state of health, 
in particular (which can be interpreted as a 
reduction in personal mobility and a simul-
taneous increase in travel costs, possibly due 
to more frequent visits to the doctor) increas-
es the personal preference for DDs. Whereas 
so-called supporting factors (local pharmacy, 
the possibility to use a car and social support), 
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which expand the personal resources or lower 
travel costs reduce the preference for DDs.
maTeRIals aND meTHODs
The analysis uses data from the “Gesund-
heitsbarometer Alter NÖ 2019”, which is a 
health-related standardised, representative 
telephone survey conducted throughout Low-
er Austria in the spring of 2019. Sampling was 
carried out using a random selection stratified 
by community size with additional screening 
according to age. The sample comprises 2,042 
people aged 60 years and older. Data were 
analysed using a logit model and analysis was 
carried out using IBM SPSS version 24.
The dependent variable is measured by 
asking about the personal importance of DDs 
with the possible answers “very important”, 
“quite important”, “less important” or “not 
important at all”. These responses are di-
chotomised: (1) Reported preference for DDs 
(options ‘very’ and ‘quite important’) and (0) 
no or little reported preference for DDs (op-
tions ‘less’ and ‘not important’).
Explanatory variables can be divided into 
three subject areas.
• Health indicators: It is assumed that the 
preference for DDs increases with poor 
health status. Health status is measured 
by three variables: an index of function-
ality regarding activities of daily living 
(ADL) with a value range of 0–10 (high to 
low functionality), the number of chronic 
diseases (20 diseases were enquired about 
leading to a value range of 0–20), and per-
ceived age. The last indicator may seem 
surprising, but it is the result of a complex 
self-assessment process. In gerontological 
research, perceived age is considered as a 
valid indicator of the general status, taking 
health, psychological and social aspects 
into account (Bowling et al., 2005; Spul-
ing et al., 2013). Feeling the same age or 
younger than the chronological age (= var-
iable age comparison) is coded as the ref-
erence category (1) and represents a posi-
tive assessment of one’s general status.
• Supportive factors, when fulfilled, should 
reduce the importance of DDs, as they en-
able independent drug supply or reduce 
travel costs. In the statistical model, the 
following are used as indicators: the abil-
ity to drive a car, as it allows to reach more 
distant pharmacies (which is especially 
important in rural areas as often found 
in Lower Austria), the presence of a phar-
macy in the place of residence, and social 
support in case of illness (e.g. to pick up 
medication).
• Gender and chronological age are included 
as control variables.
ResUlTs
The analysed sample includes 1,876 observa-
tions due to missing values. With Nagelkerke’s 
R2 at 0.124 and the Hosmer–Lemeshow test 
at 0.71, the model is deemed acceptable. Re-
sults are shown in table 1. The logistic model 
indicates that with a one point drop in func-
tionality (ADL) the probability of preferring a 
DD increases (OR: 1.14; 95% CI: 1.05–1.25). 
The age comparison is also influential (OR: 
2.03; 95% CI: 1.46–2.83), while the number 
of chronic diseases is not significantly power-
ful. Testing supportive factors, the presence of 
a pharmacy at the place of residence is signif-
icantly associated with a lower likelihood of 
having a preference for DDs (OR: 0.44; 95% 
CI: 0.35–0.55), regardless of the other fac-
tors. The ability to use a car by oneself also 
reduces the likelihood to report a preference 
for DD. Consequently, the inability to use a 
car increases the chance of considering DDs 
as important (OR: 1.54; 95% CI: 1.13–2.09). 
No statistically significant relationship can be 
found with either social support, chronologi-
cal age or gender.
DIsCUssION
Based on survey data of older adults in Lower 
Austria, this article examines the relationship 
between preference for dispensing doctors 
and determining factors. Firstly, the results 
show that having a pharmacy at the place of 
residence as well as the ability to independent-
ly use a car reduces the probability of prefer-
ring DDs. Both are understandable when we 
look at Lower Austria – which encompasses 
large-area communities with a small number 
of inhabitants and a varying degree of public 
transport. It is therefore assumed that, travel 
costs to the nearest pharmacy are relatively 
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Odds 
ratio 95% Ci Wald Sig.
Health indicators
Functional index 1.148 1.051 1.254 0.298 0.002
Number of chronic diseases 1.021 0.947 1.101 50.671 0.585
Age comparison 
(Ref. Feeling the same age or 
younger)
2.039 1.468 2.831 1.916 0.000
Supportive factors
Car usage  
(Ref. independent) 1.545 1.138 2.099 0.016 0.005
Presence of pharmacy  
(Ref. No pharmacy in village) 0.441 0.352 0.553 7.763 0.000
Social support  
(Ref. No/little support) 1.032 0.638 1.669 18.090 0.899
Control variables
Chronological age 1.011 0.996 1.026 1.379 0.166
Gender  





Table 1 – logistic model of determinants of older people’s preferences for dispensing 
doctors
high for many of the respondents. This asso-
ciation is in accordance with a study by Sun-
derland et al. (2006) which also shows that 
travel and fuel costs are perceived as barriers 
to accessing medication by patients. Secondly, 
our study reveals that increasing limitation of 
functionality in everyday life leads to elderly 
people prefering DDs (probability increases 
by 15% per unit), while the number of chron-
ic diseases does not influence the preference. 
Chronic diseases cannot be equated with mo-
bility impairment per se, whereas the index 
of functionality regarding everyday activities 
is an indicator of a person’s range of action. 
Additionally, a negative age comparison (feel-
ing older than you are) – i.e. a negative assess-
ment of the subjective general status – has a 
particularly strong influence on the attitude 
towards DDs. This is understandable, consid-
ering that feeling older than one’s chronolog-
ical age is usually associated with a negative 
state of health (Spuling et al., 2013), plus the 
validity of prescriptions and number of dis-
pensations per prescription are normally lim-
ited in Austria. The combination of these as-
pects leads to higher travel costs due to more 
frequent visits to the doctor and pharmacy.
In summary, the preference for DDs is 
strongly framed by the accessibility of a phar-
macy and thus follows the theoretical frame 
of Eggleston (2012) – which refers to the 
question of integration or separation of pre-
scription and dispensation on the factor of 
travel costs. Bannert and Iselin (2015) state 
that DDs provide better pharmaceutical cov-
erage in rural areas where pharmacies cannot 
exist, and Weiss et al. (2016) note that DDs 
see themselves as a ‘one-stop shop’ and point 
to ‘reduced travel costs and more accessible 
for rural’ patients. The present study con-
firms that patient preference for DDs increas-
es under factors that can be seen as an exten-
sion of perceived travel costs, which supports 
the above-mentioned studies. Despite am-
biguous scientific findings on the advantag-
es/disadvantages of DDs (Lim et al., 2009), 
our study indicates a supplemental structure 
between both dispensing systems. From the 
(elderly) patient’s point of view, the combi-
nation of the two systems is beneficial as it 
increases the density of medication supply. 
A pharmacy at the place of residence can only 
outweigh the preference for DDs if it is acces-
sible for older people – taking low (monetary 
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and personally perceived) travel costs into 
account.
CONClUsIONs
As the state of current research shows, there 
is a lively scientific, but also political debate 
about the advantages and disadvantages of 
DDs. Little attention is paid to the wishes 
and ideas of older patients. The present study 
points out that factors restricting mobility 
or increasing (monetary and personally per-
ceived) travel costs play a role in the prefer-
ences of the population. In the end, the aim 
must be to ensure the best possible supply of 
medication, which means to improve access to 
medicines in all communities – in particular 
where there is no pharmacy within a reason-
able distance for people with health problems 
or those with restricted mobility. In these cas-
es, DDs can be an adequate answer.
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